Symptom groups associated with adult onset inborn errors of metabolism
Disorder | Other symptoms | Tests | ||
Muscle weakness or exercise intolerance | ||||
Fatty acid oxidation defects | ±Cardiomyopathy±hypoglycaemia±liver disease±myoglobinuria | Urine organic acids (fasting) | ||
Glycolytic pathway disorders | ±Anaemia ±liver disease, muscle weakness ±cardiomyopathy±endocrinological disorders±ptosis | Red cells or muscle biopsy for enzyme assays | ||
Glycogen storage diseases | ||||
(a) Type II (acid maltase deficiency) | ±Respiratory difficulties due to diaphragmatic weakness | Lymphocyte acid α-glucosidase | ||
(b) Type III (Cori's disease) | History of early hypoglycaemia and hepatomegaly | Leucocyte glycogen debrancher enzyme assay | ||
(c) Type V (McArdle's disease) | Myoglobinuria, exercise intolerance, cramps | Ischaemic exercise test | ||
(d) Phosphorylase b kinase deficiency | ±Cardiomyopathy ±liver disease | Erythrocyte or liver phosphorylase b kinase assay | ||
Myoadenylate deaminase deficiency | Note: most persons are asymptomatic | Ischaemic exercise test (increased ammonia), muscle biopsy for myoadenylate deaminase assay, blood for DNA analysis for the common mutation. | ||
Motor neuron disease | ||||
Adult polyglucosan storage disease | Dementia, neurogenic bladder, sensory loss | Leucocyte glycogen brancher assay (some forms may show normal muscle activity). | ||
GM2 Gangliosidosis (Tay-Sach's and Sandhoff's disease) | Slow progressive disorder, pyramidal signs, cerebellar degeneration | Leucocyte total hexosaminidase and hexosaminidase A | ||
Chorea and/or dystonia | ||||
Glutamic aciduria type 1 | ±Reye's syndrome | Urine organic acids | ||
±Hypoglycaemia, slow progressive disorder, gait disturbance, dysarthria | blood spot for acyl carnitines | |||
GM2 Gangliosidosis (Tay-Sach's and Sandhoff's disease) | Slow progressive disorder | Leucocyte total hexosaminidase and hexosaminidase A | ||
Lesch-Nyhan syndrome | Renal stones | Plasma urate and urine, urate/creatinine ratio | ||
Methylmalonic aciduria with homocystinuria | ±Anaemia | Urine organic acids and amino acids. urine , and plasma homocystine. | ||
Niemann-Pick disease type C | Supranuclear ophthalmoplegia, ataxia, psychomotor retardation, dementia, splenomegaly | Bone marrow aspirate fibroblast cholesterol incorporation and staining | ||
Segawa disease | Diurnal variation of symptoms | Levodopa trial (some forms have a defect in biopterin metabolism) | ||
Wilson's disease | Kayser-Fleischer rings,±liver disease ±dementia ±choreoathetosis ±renal failure | Plasma copper and caeruloplasmin, urine copper (pre and postpenicillamine), liver copper | ||
Ataxia | ||||
Abetalipoproteinaemia | Muscle weakness, fat malabsorption, retinitis pigmentosa | Plasma cholesterol and triglycerides, blood film (acanthocytes), lipoproteins | ||
Acaeruloplasminaemia | ±Presenile dementia ±diabetes mellitus, retinal dystrophy | Plasma and urine copper | ||
Cerebrotendinous xanthomatosis | Spasticity, cataracts, tendon xanthomas | Urine cholestanol | ||
GM2 Gangliosidosis (Tay-Sachs' and Sandhoff's disease) | Slow progressive disorder | Leucocyte total hexosaminidase and hexosaminidase A | ||
Hartnup disease | ±Skin lesions | Plasma and urine amino acids | ||
Niemann-Pick disease type C | ±Supranuclear ophthalmoplegia, dementia, dystonia, splenomegaly | Bone marrow aspirate | ||
Pyruvate dehydrogenase deficiency (X linked) | Episodes in males triggered by carbohydrate feeding | Pre and postprandial blood lactate, CSF lactate, fibroblast pyruvate dehydrogenase | ||
Refsum's disease | Retinitis pigmentosa, polyneuropathy | Plasma phytanic acid | ||
Sialidosis (mucolipidosis type I) | Type I | Urine oligosaccharides | ||
Visual defect with lens or corneal opacity, ataxia, myoclonus, generalised seizures sometimes with nystagmus, ataxia, dementia ± cherry red spot | fibroblast α-neuraminidase | |||
Type II | ||||
Myoclonus, blindness, cherry red spot, dysmorphic features, angiokeratoma. | ||||
Leukodystrophy (diagnosed radiologically) | ||||
Krabbe's leukodystrophy | Pes cavus, hemiparesis, spastic tetraparesis | Leucocyte β-galactocerebrosidase | ||
Metachromatic leukodystrophy | Slow progressive disorder, impaired nerve conduction ±behavioural problems | Leucocyte arylsulphatase A (common pseudodeficiency state must be excluded) | ||
X linked adrenoleukodystrophy | Males | Plasma very long chain fatty acids | ||
Gait disturbance, spastic paraparesis, rarely dementia ±Addison's disease | ||||
Females | ||||
Onset >30 y, spastic paraparesis, vibration sense loss, long tract signs, peripheral neuropathy | ||||
Strokes and stroke-like episodes: | ||||
Fabry's disease | Angiokeratoma, renal disease, developmental delay | Leucocyte α-galactosidase A | ||
Homocystinuria | Lens dislocation,occlusive cerebrovascular disease, osteoporosis, skeletal deformities, mental retardation | Urine homocystine | ||
Mitochondrial myopathy, encephalopathy with lactic acidaemia and stroke-like episodes (MELAS) | Seizures, developmental delay, sensorineural hearing loss ±diabetes mellitus | Blood for mtDNA analysis | ||
Urea cycle defects | Postprandial vomiting, coma, confusion | Blood ammonia, plasma, and urine amino acids | ||
Behavioural and/or psychiatric disorders and/or dementia | ||||
Acaeruloplasminaemia | Ataxia, diabetes mellitus, retinal dystrophy | Plasma copper and caeruloplasmin, plasma iron and ferritin | ||
Gaucher's disease type III | Horizontal supranuclear gaze defect, developmental delay, hydrocephalus, skeletal abnormalities psychosis | Leucocyte β-glucosidase, bone marrow aspirate | ||
Hartnup disease | Ataxia and skin lesions | Plasma and urine amino acids | ||
Homocystinuria (classic) | Occlusive cerebrovascular disease, dislocated lenses, osteoporosis, skeletal deformities. | Urine and plasma homocystine and methionine. | ||
Homocystinuria (remethylation defect) | Paraesthesia, limb weakness, mental retardation | Urine and plasma homocystine and methionine. | ||
Juvenile Batten's disease | Visual loss, seizures, retinitis pigmentosa | Skin or rectal biopsy for histological analysis, DNA for the common deletion | ||
Kuf's disease | Dementia, psychosis, motor loss | Skin or rectal biopsy for histological analysis | ||
Metachromatic leukodystrophy | Slow progressive disorder, impaired nerve conduction, leukodystrophy | Leucocyte arylsulphatase A (pseudodeficiency state must be excluded) | ||
Niemann-Pick disease type C | Vertical supranuclear ophthalmoplegia, psychomotor retardation, ataxia, dystonia, splenomegaly | Bone marrow aspirate, fibroblast cholesterol incorporation and staining | ||
Ornithine transcarbamylase deficiency | Episodic symptoms (often postprandial), sleep disorders, comatose episodes | Plasma ammonia (1h postprandial), plasma amino acids, urine amino acids and orotic acid | ||
Porphyriria | Limb, neck, or chest pain, muscle weakness, abdominal pain, photosensitivity. | Urine and fecal porphyrins, urine delta aminolaevulinic acid and porphobilinogen | ||
Wilson's disease | Kayser-Fleischer rings ±liver disease, dysarthria, loss of coordination, pseudobulbar palsy , parkinsonian features | Plasma copper and caeruloplasmin | ||
X linked adrenoleukodystrophy | Gait disturbance ±Addison's disease | Plasma very long chain fatty acids | ||
leukodystrophy, spastic paraparesis, impotence | ||||
Eye disorders | ||||
Cerebrotendinous xanthomatosis | Spasticity, cataracts, tendon xanthomas | Urine cholestanol | ||
Galactokinase deficiency | Cataracts | Postprandial urine sugar, chromatography | ||
Gaucher's disease type III | Horizontal supranuclear gaze defect, developmental delay, hydrocephalus, skeletal abnormalities, psychosis | Leucocyte β-glucosidase | ||
Homocystinuria (classic form) | Lens dislocation, occlusive cerebrovascular disease, osteoporosis, skeletal deformities, mental retardation | Urine and plasma homocystine and methionine | ||
Hyperornithinaemia with gyrate atrophy of the retina | Optic atrophy | Plasma and urine amino acids (ornithine) | ||
Juvenile Batten's disease | Seizures, visual loss, retinitis pigmentosa, dementia | Skin or rectal biopsy for histological analysis, blood for DNA analysis for the common mutation | ||
Leber's hereditary optic atrophy | Bilateral optic atrophy (may be alcohol or tobacco triggered) | Blood for mtDNA analysis | ||
Neuropathy ataxia and retinitis pigmentosa (NARP) | Retinitis pigmentosa, ataxia, neuropathy | Blood for mtDNA analysis | ||
Niemann-Pick disease type C | Psychomotor retardation leading to dementia ataxia with dystonia, vertical supranuclear ophthalmoplegia | Bone marrow aspirate, fibroblast cholesterol uptake and staining. | ||
Oculocutaneous albinism | Pale complexion, blue eyes | Hair follicle tyrosinase | ||
Refsum's disease | Peripheral neuropathy, retinitis pigmentosa, cerebellar ataxia | Plasma phytanic acid | ||
Sialidosis (mucolipidosis type I) | Type I | Urine oligosaccharides | ||
Visual defect with lens or corneal opacityataxia, myoclonus, generalised seizures sometimes with nystagmus, ataxia, dementia ± cherry red spot | Fibroblast α-neuraminidase | |||
Type II | ||||
Myoclonus, blindness, cherry red spot, dysmorphic features, angiokeratoma. | ||||
Tyrosinaemia type II | Cataracts, skin lesions, slight developmental delay | Plasma and urine amino acids | ||
Wilson's disease | Cataracts, Kayser-Fleischer rings, liver disease, dementia, renal failure, parkinsonian features, dysarthria, loss of coordination of voluntary movement. | Plasma copper and caeruloplasmin | ||
Epilepsy | ||||
Electron transport chain disorders | Any combination of symptoms | CSF and blood lactate, blood mtDNA analysis, muscle biopsy for enzyme assay. | ||
Juvenile Batten's disease | Visual loss | Skin or rectal biopsy for histological analysis, DNA for the common mutation | ||
Kuf's disease | Progressive myoclonic epilepsy | Skin or rectal biopsy for histological analysis | ||
Myoclonic epilepsy with ragged red fibres | Myoclonus | Blood for mtDNA analysis. | ||
Pyridoxine dependent seizures | Persistent seizures responsive to pyridoxine | Pyridoxine response trial (primary defect not known) | ||
Sialidosis (mucolipidosis type I) | Type I | Urine oligosaccharides | ||
Visual defect with lens or corneal opacityataxia, myoclonus, generalised seizures sometimes with nystagmus, ataxia, dementia±cherry red spot | Fibroblast α-neuraminidase | |||
Type II | ||||
Myoclonus, blindness, cherry red spot, dysmorphic features, angiokeratoma |